Recent Finacing
Recent Raise
ExeVir Bio is a Ghent-based clinical-stage biotech developing llama-derived VHH single-domain multi-specific antibodies for viral diseases (COVID-19, dengue), advancing candidates into clinical trials and scaling manufacturing.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
